R. Gendreau
Chief Tech/Sci/R&D Officer at VIRIOS THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Profile
R.
Michael Gendreau is the founder of Cypress Bioscience, Inc. founded in 1981, where he held the position of Chief Medical Officer and VP-Research & Development from 1995 to 2011.
He is currently the Chief Medical Officer at Virios Therapeutics, Inc. since 2012 and at Cerephex Corp.
He has previously held the position of Chief Medical Officer and VP-Research & Development at Microprobe Corp.
from 1991 to 1994, Vice President-Research & Development at Source Scientific, Inc. in 1991, and Manager-Worldwide Health Care Technology at Battelle Memorial Institute from 1988 to 1988.
He was also the Chief Medical Officer at Intec Pharma Ltd.
from 2018 to 2020.
Dr. Gendreau received his undergraduate degree from The Ohio University and his doctorate from The Ohio State University College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-24 | 0 ( -.--% ) | - $ | 2024-04-29 |
R. Gendreau active positions
| Companies | Position | Start |
|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2012-02-27 |
Cerephex Corp.
 Cerephex Corp. Medical SpecialtiesHealth Technology Cerephex Corp. develops and provides therapies and diagnostic technologies for chronic centralized pain. It offers NeuroPoint, a point-of-care medical device that is built upon patented reduced impedance noninvasive cortical electrostimulation signal technology platform developed to unable use by physician-supervised staff in existing clinical outpatient offices. The company was founded by Jeffrey Hargrove and Robert M. Ford on September 26, 2012 and is headquartered in Los Altos, CA. | Chief Tech/Sci/R&D Officer | - |
Former positions of R. Gendreau
| Companies | Position | End |
|---|---|---|
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Chief Tech/Sci/R&D Officer | 2020-10-30 |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Founder | 2010-12-31 |
Microprobe Corp.
 Microprobe Corp. Miscellaneous Commercial ServicesCommercial Services Microprobe Corp. is an American company that specializes in commercial medical research. | Chief Tech/Sci/R&D Officer | 1993-12-31 |
| Source Scientific, Inc. | Chief Tech/Sci/R&D Officer | 1990-12-31 |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Corporate Officer/Principal | 1987-12-31 |
Training of R. Gendreau
| The Ohio University | Undergraduate Degree |
| The Ohio State University College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Microprobe Corp.
Microprobe Corp. Miscellaneous Commercial ServicesCommercial Services Microprobe Corp. is an American company that specializes in commercial medical research. | Commercial Services |
| Source Scientific, Inc. | Health Technology |
Battelle Memorial Institute
Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Commercial Services |
Cerephex Corp.
Cerephex Corp. Medical SpecialtiesHealth Technology Cerephex Corp. develops and provides therapies and diagnostic technologies for chronic centralized pain. It offers NeuroPoint, a point-of-care medical device that is built upon patented reduced impedance noninvasive cortical electrostimulation signal technology platform developed to unable use by physician-supervised staff in existing clinical outpatient offices. The company was founded by Jeffrey Hargrove and Robert M. Ford on September 26, 2012 and is headquartered in Los Altos, CA. | Health Technology |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
- Stock Market
- Insiders
- R. Gendreau
